| abstract |
The present invention relates to a method of subcutaneous administration of an antibody (anti-TNF-α antibody) that binds TNF-α via a TNF-α-related disease. According to the treatment method, composition, reagent set or use of the present invention, the administration time and the hospitalization time of the patient are shortened, thereby improving the convenience of the patient and the quality of life of the patient. This provides the advantage of improving patient satisfaction. |